Sotalol Hydrochloride Tablet
Product Images NDC 69584-841

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Sotalol Hydrochloride (NDC 69584-841). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Oxford Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

69584-841-10 (69584 841 10)

FDA Label Image

69584-842-10 (69584 842 10)

69584-842-10 (69584 842 10)
This is a description of a medication called "Sotalol P Hydrochloride". It comes in the form of 100 tablets and is available only with a prescription. The manufacturer of the medication is Oxford Pharmaceuticals, LLC.*
FDA Label Image

69584-843-10 (69584 843 10)

69584-843-10 (69584 843 10)
This is a description of a medication. The medication is Sotalol Hydrochloride, in tablet form. The package contains 100 tablets, and the manufacturer is Oxford Pharmaceuticals, LLC, based in Birmingham, Alabama. The product details include the NDC number, dosage, prescription requirements, and manufacturing date/address. There is also a serialization area and a unique product serial number.*
FDA Label Image

69584-844-10 (69584 844 10)

69584-844-10 (69584 844 10)
This is a description of a bottle of Sotalol Hydrochloride Tablets, USP manufactured by Oxford Pharmaceuticals LLC containing 100 tablets. The bottle has a unique serial number printed on it. The rest of the text appears to be illegible or gibberish.*
FDA Label Image

Age About 2 Years Or Younger (Age Factor)

FDA Label Image

Figure 2 (Figure2)

Figure 2 (Figure2)
The text shows the p-value for Recurrence-Free Survival (RFS) for the comparison between Oral Sotalol and Placebo in doses of 80mg, 120mg, and 160mg. This information suggests that these are the p-values for different dose groups in a clinical trial, where a lower p-value suggests a significant difference between the treatment and placebo groups. Therefore, this information is relevant for evaluating the efficacy of Oral Sotalol.*
FDA Label Image

Figure 3 (Figure3)

FDA Label Image

Molecular Structure (Molecularstructure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.